- Presentations
- 2
- Markets
- 1
Exparel is a brand of Bupivacaine marketed by Pacira Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Bupivacaine
- Brand owner
- Pacira Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 133 mg/10 mL liposomal injectable suspension, 266 mg/20 mL liposomal injectable suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Exparel 133 mg/10 mL liposomal injectable suspensionInfiltration | Pacira Pharmaceuticals | US FDA | Available on request |
| Exparel 266 mg/20 mL liposomal injectable suspensionInfiltration | Pacira Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Bupivacaine.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Exparel
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.